Ftse Mib
33.167,64
-0,78%
DAX
19.295,98
-0,59%
S&P 500
6.021,63
0,57%
NASDAQ
19.175,58
0,63%
Bitcoin
92.354,56
0,42%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Europa EU Innate Pharma (IPH) Innate Pharma (IPH) Notizie

Innate Pharma

IPH
1,432
0,004 (0,28%)
26 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: Euronext
Tipo: Azione Ordinaria
Valuta: EUR

Ultime notizie

Data Ora Fonte Titolo
20/11/202407:00BWInnate Pharma Releases Its 2025 Financial Calendar
19/11/202407:00BWInnate Pharma annonce une publication dans la revue Science..
13/11/202407:00BWInnate Pharma Reports Third Quarter 2024 Business Update and..
08/11/202407:00BWInnate Pharma annonce les présentations de données de son..
07/11/202407:00BWInnate Pharma organise une conférence téléphonique pour ses..
29/10/202407:00BWInnate Pharma Announces Its Participation in Upcoming..
14/10/202407:00BWInnate Pharma Appoints Jonathan Dickinson as New Chief..
30/9/202407:00BWInnate Pharma co-organise un symposium scientifique en..
23/9/202407:00BWInnate Pharma Announces FDA Clearance of the IND for..
12/9/202407:00BWInnate Pharma Reports First Half 2024 Business Update and..
09/9/202407:00BWInnate Pharma SA: Monalizumab Data From NeoCOAST-2 Phase 2..
05/9/202407:00BWInnate Pharma organise une conférence téléphonique pour..
04/9/202407:00BWInnate Pharma annonce sa participation à la 26ème Annual..
01/8/202407:00BWInnate Pharma Announces Its Participation in Upcoming..
25/7/202407:00BWNumber of Shares and Voting Rights of Innate Pharma as of..
18/6/202407:00BWNouveau nombre d’actions et de droits de vote d’Innate..
17/6/202407:00BWInnate Pharma partage de nouveaux résultats concernant..
04/6/202407:00BWInnate Pharma présente les résultats positifs de l’étude de..
28/5/202407:00BWInnate Pharma Announces Its Participation in Upcoming..
24/5/202407:00BWInnate Pharma Highlights Abstracts Selected for ASCO 2024..
23/5/202422:00BWOutcome of Innate Pharma’s 2024 Annual General Meeting
21/5/202407:00BWInnate Pharma: Clarification Regarding SAR443579 Designation
15/5/202407:00BWInnate Pharma partage les abstracts sélectionnés pour le..
14/5/202407:00BWInnate Pharma Reports First Quarter 2024 Business Update and..
07/5/202407:00BWInnate Pharma Announces Conference Call and Webcast for Q1..
15/4/202407:00BWL’Assemblée Générale d’Innate Pharma aura lieu le 23 mai..
10/4/202407:00BWInnate Pharma Presents at AACR 2024 Preclinical Efficacy of..
09/4/202407:00BWInnate Pharma Announces Its Participation in Upcoming..
05/4/202409:34BWInnate Pharma Files Its 2023 Universal Registration Document..
21/3/202407:00BWInnate Pharma Reports Full Year 2023 Financial Results and..
19/3/202407:00BWInnate Pharma annonce sa participation à une prochaine..
14/3/202407:00BWInnate Pharma Announces Conference Call and Webcast for Full..
06/3/202407:00BWInnate Pharma: First Patient dosed in Phase 1/2 study of..
21/2/202407:00BWInnate Pharma Announces Its Participation to Upcoming..
12/1/202407:00BWNumber of Shares and Voting Rights of Innate Pharma as of..
04/1/202407:00BWInnate Pharma annonce que l’agence américaine du médicament..
04/1/202406:59BWInnate Pharma renforce son équipe de direction et nomme deux..
19/12/202313:28DJNInnate Pharma Shares Rise after Sanofi Exercises Licensing..
19/12/202307:00BWInnate Pharma Announces Licensing of a Fourth Natural Killer..
18/12/202307:00BWInnate Pharma annonce un changement de direction
11/12/202307:00BWInnate Pharma Shares Efficacy and Safety Phase 1 /2 Results..
10/12/202307:00BWInnate Pharma Presents Positive Results From TELLOMAK Phase..
Apertura: 1,45 Min: 1,416 Max: 1,494
Chiusura: 1,428

La tua Cronologia

EU
IPH
Innate Pharma
AMEX
ILI
Interleukin Genetics
TSX
XFN
iShares S&P TSX Capped F...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network